Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity: A phase II evaluation. The Rembrandt Investigators.
H. Büller, R. Cariou, A. Gallus, M. Gent +106 more
2000Circulation109 citations
Semantic Scholar

